Richard Crowley, EVP Biopharmaceutical Operatio at SAVIENT PHARMACEUTICALS INC (SVNT), bought 3,000 shares at $2.53 ($8K) on 2011-11-21, disclosed to the SEC on 2011-11-22.
Open-market purchase of $8k SVNT by EVP Biopharmaceutical Operatio. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SVNT | SELL | 2013-02-06 | $51K | — | Filing → |
| SVNT | SELL | 2013-02-04 | $2K | — | Filing → |
| SVNT | SELL | 2012-11-06 | $3K | — | Filing → |